Stroke  >>  Activase (alteplase)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe
NCT01282242: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients

Completed
2a
88
US
IV rt-PA, Alteplase, Activase
Lee Schwamm, National Institute of Neurological Disorders and Stroke (NINDS), Genentech, Inc.
Acute Stroke
01/16
05/16
NCT00238537: Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)

Completed
2
100
Europe, RoW
Alteplase t-PA
Melbourne Health, Boehringer Ingelheim
Stroke
 
04/07
Wake-Up Stroke, NCT01183533: Safety of Intravenous Thrombolysis for Wake-up Stroke

Completed
2
40
US
Alteplase (iv t-PA), Activase®, Alteplase, tissue plasminogen activator, t-PA
The University of Texas Health Science Center, Houston, Genentech, Inc.
Ischemic Stroke
10/13
01/14
SAIL-ON, NCT01643902: Safety of Intravenous Thrombolytics in Stroke on Awakening

Completed
2
20
US
tPA, Activase, Alteplase
Johns Hopkins University, Genentech, Inc.
Stroke
12/15
12/15

Download Options